Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Zinoact is a patented steamed ginger extract developed by 3H Labs, positioned as a nutraceutical and functional ingredient. It is produced using a proprietary steaming and drying process designed to enhance the potency of bioactive phenolic compounds, including gingerols, shogaols, paradols, and zingerone. Mechanistically, Zinoact acts as an activator of adenosine monophosphate-activated protein kinase (AMPK), a key metabolic regulator that helps reduce fat storage and improve glucose uptake in muscle cells. Clinical research has associated the ingredient with improvements in metabolic health markers, including reductions in body weight, BMI, waist and hip circumference, triglycerides, and total cholesterol. Beyond metabolic applications, Zinoact has been studied for its benefits in joint health, specifically for reducing pain and stiffness in individuals with mild knee osteoarthritis, and for its potential to enhance exercise endurance.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Zinoact.